152 related articles for article (PubMed ID: 32280024)
1. Clinical inertia among health care providers in a public health safety-net clinic in the management of type 2 diabetes.
Lingow SE; Guyton JE
J Am Pharm Assoc (2003); 2020; 60(5):734-739. PubMed ID: 32280024
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated with Diabetes-Related Clinical Inertia in a Managed Care Population and Its Effect on Hemoglobin A1c Goal Attainment: A Claims-Based Analysis.
Ruiz-Negrón N; Wander C; McAdam-Marx C; Pesa J; Bailey RA; Bellows BK
J Manag Care Spec Pharm; 2019 Mar; 25(3):304-313. PubMed ID: 30816810
[TBL] [Abstract][Full Text] [Related]
3. Assessment of clinical inertia in people with diabetes within primary care.
Meredith AH; Buatois EM; Krenz JR; Walroth T; Shenk M; Triboletti JS; Pence L; Gonzalvo JD
J Eval Clin Pract; 2021 Apr; 27(2):365-370. PubMed ID: 32548871
[TBL] [Abstract][Full Text] [Related]
4. Pharmacist Impact on Treatment Intensification and Hemoglobin A
Cowart K; Sando K
J Pharm Pract; 2019 Dec; 32(6):648-654. PubMed ID: 29768945
[TBL] [Abstract][Full Text] [Related]
5. Patient and Provider Factors Affecting Clinical Inertia in Patients With Type 2 Diabetes on Metformin Monotherapy.
Mahabaleshwarkar R; Gohs F; Mulder H; Wilkins N; DeSantis A; Anderson WE; Ejzykowicz F; Rajpathak S; Norton HJ
Clin Ther; 2017 Aug; 39(8):1658-1670.e6. PubMed ID: 28689692
[TBL] [Abstract][Full Text] [Related]
6. Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes.
Gerber BS; Rapacki L; Castillo A; Tilton J; Touchette DR; Mihailescu D; Berbaum ML; Sharp LK
BMC Public Health; 2012 Oct; 12():891. PubMed ID: 23088168
[TBL] [Abstract][Full Text] [Related]
7. Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
Morello CM; Nguyen T; Tao L; Hirsch JD
Ann Pharmacother; 2020 Sep; 54(9):858-865. PubMed ID: 32100551
[No Abstract] [Full Text] [Related]
8. Clinical Outcomes Associated With a Collaborative Pharmacist-Endocrinologist Diabetes Intense Medical Management "Tune Up" Clinic in Complex Patients.
Morello CM; Christopher ML; Ortega L; Khoan J; Rotunno T; Edelman SV; Henry RR; Hirsch JD
Ann Pharmacother; 2016 Jan; 50(1):8-16. PubMed ID: 26546580
[TBL] [Abstract][Full Text] [Related]
9. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus.
McFarland M; Davis K; Wallace J; Wan J; Cassidy R; Morgan T; Venugopal D
Pharmacotherapy; 2012 May; 32(5):420-6. PubMed ID: 22488512
[TBL] [Abstract][Full Text] [Related]
10. Implementation of a pharmacist-led diabetes management service in an endocrinology clinic.
Parsiani R; Lundy R; Ahmann A; Joarder F; Castle J
J Am Pharm Assoc (2003); 2022; 62(6):1855-1859. PubMed ID: 36089458
[TBL] [Abstract][Full Text] [Related]
11. Measurement of Pharmacist-Physician Collaborative Care on Therapeutic Inertia in Patients With Type 2 Diabetes.
Cowart K; Emechebe N; Pathak R; Abbruzese L; Hann J; Lloyd A; Roetzheim R; Zgibor J; Updike WH
Ann Pharmacother; 2022 Feb; 56(2):155-161. PubMed ID: 34105397
[TBL] [Abstract][Full Text] [Related]
12. Glycemic control and preventive care measures of indigent diabetes patients within a pharmacist-managed insulin titration program vs standard care.
Salvo MC; Brooks AM
Ann Pharmacother; 2012 Jan; 46(1):29-34. PubMed ID: 22202497
[TBL] [Abstract][Full Text] [Related]
13. Pharmacists' impact on improving outcomes in patients with type 2 diabetes mellitus.
Pepper MJ; Mallory N; Coker TN; Chaki A; Sando KR
Diabetes Educ; 2012; 38(3):409-16. PubMed ID: 22523190
[TBL] [Abstract][Full Text] [Related]
14. Clinical Pharmacist Team-Based Care in a Safety Net Medical Home: Facilitators and Barriers to Chronic Care Management.
Price-Haywood EG; Amering S; Luo Q; Lefante JJ
Popul Health Manag; 2017 Apr; 20(2):123-131. PubMed ID: 27124294
[TBL] [Abstract][Full Text] [Related]
15. Improved Glycemic Control With Minimal Change in Medication Regimen Complexity in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
Morello CM; Rotunno T; Khoan J; Hirsch JD
Ann Pharmacother; 2018 Nov; 52(11):1091-1097. PubMed ID: 29775079
[TBL] [Abstract][Full Text] [Related]
16. Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility.
Wallgren S; Berry-Cabán CS; Bowers L
Ann Pharmacother; 2012 Mar; 46(3):353-7. PubMed ID: 22395249
[TBL] [Abstract][Full Text] [Related]
17. DOES CLINICAL INERTIA VARY BY PERSONALIZED A1C GOAL? A STUDY OF PREDICTORS AND PREVALENCE OF CLINICAL INERTIA IN A U.S. MANAGED-CARE SETTING.
Lin J; Zhou S; Wei W; Pan C; Lingohr-Smith M; Levin P
Endocr Pract; 2016 Feb; 22(2):151-61. PubMed ID: 26492540
[TBL] [Abstract][Full Text] [Related]
18. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial.
Suppapitiporn S; Chindavijak B; Onsanit S
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S134-41. PubMed ID: 16623018
[TBL] [Abstract][Full Text] [Related]
19. Evaluating Therapeutic Inertia in Two Telehealth Interventions for Type 2 Diabetes: Secondary Analyses of a Randomized Trial.
Duffy RA; Jeffreys AS; Coffman CJ; Alexopoulos AS; Tarkington PE; Bosworth H; Edelman D; Crowley MJ
Telemed J E Health; 2024 Jun; 30(6):e1790-e1797. PubMed ID: 38377570
[No Abstract] [Full Text] [Related]
20. Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System.
Pantalone KM; Wells BJ; Chagin KM; Ejzykowicz F; Yu C; Milinovich A; Bauman JM; Kattan MW; Rajpathak S; Zimmerman RS
Diabetes Care; 2016 Sep; 39(9):1527-34. PubMed ID: 27519447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
